Foghorn Therapeutics Inc. Annual Interest Paid, Excluding Capitalized Interest, Operating Activities in USD from 2019 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.
Summary
Foghorn Therapeutics Inc. annual/quarterly Interest Paid, Excluding Capitalized Interest, Operating Activities history and growth rate from 2019 to 2023.
  • Foghorn Therapeutics Inc. Interest Paid, Excluding Capitalized Interest, Operating Activities for the quarter ending March 31, 2022 was $0.000, a 100% decline year-over-year.
  • Foghorn Therapeutics Inc. annual Interest Paid, Excluding Capitalized Interest, Operating Activities for 2023 was $3.55M.
  • Foghorn Therapeutics Inc. annual Interest Paid, Excluding Capitalized Interest, Operating Activities for 2022 was $0.000, a 100% decline from 2021.
  • Foghorn Therapeutics Inc. annual Interest Paid, Excluding Capitalized Interest, Operating Activities for 2021 was $1.72M, a 160% increase from 2020.
Interest Paid, Excluding Capitalized Interest, Operating Activities, Annual (USD)
Interest Paid, Excluding Capitalized Interest, Operating Activities, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $3.55M +$3.55M Jan 1, 2023 Dec 31, 2023 10-K 2024-03-07
2022 $0 -$1.72M -100% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-07
2021 $1.72M +$1.06M +160% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-09
2020 $660K +$240K +57.1% Jan 1, 2020 Dec 31, 2020 10-K/A 2022-08-09
2019 $420K Jan 1, 2019 Dec 31, 2019 10-K 2021-03-18
* An asterisk sign (*) next to the value indicates that the value is likely invalid.